DNA Chip Research Inc. (2397.T)

JPY 653.0

(-1.51%)

Total Liabilities Summary of DNA Chip Research Inc.

  • DNA Chip Research Inc.'s latest annual total liabilities in 2023 was 250.12 Million JPY , up 55.85% from previous year.
  • DNA Chip Research Inc.'s latest quarterly total liabilities in 2024 Q1 was 229 Million JPY , down -8.44% from previous quarter.
  • DNA Chip Research Inc. reported annual total liabilities of 160.48 Million JPY in 2022, up 46.55% from previous year.
  • DNA Chip Research Inc. reported annual total liabilities of 109.5 Million JPY in 2021, up 21.19% from previous year.
  • DNA Chip Research Inc. reported quarterly total liabilities of 250.12 Million JPY for 2023 Q4, up 39.54% from previous quarter.
  • DNA Chip Research Inc. reported quarterly total liabilities of 179.24 Million JPY for 2023 Q3, up 13.53% from previous quarter.

Annual Total Liabilities Chart of DNA Chip Research Inc. (2023 - 2019)

Historical Annual Total Liabilities of DNA Chip Research Inc. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 250.12 Million JPY 55.85%
2022 160.48 Million JPY 46.55%
2021 109.5 Million JPY 21.19%
2020 90.36 Million JPY 9036000.0%
2019 1000.00 JPY 0.0%

Peer Total Liabilities Comparison of DNA Chip Research Inc.

Name Total Liabilities Total Liabilities Difference
Shin Nippon Biomedical Laboratories, Ltd. 42.14 Billion JPY 99.406%
Cosmo Bio Company,Limited 1.84 Billion JPY 86.458%
H.U. Group Holdings, Inc. 152.84 Billion JPY 99.836%
FALCO HOLDINGS Co., Ltd. 10.39 Billion JPY 97.594%
BML, Inc. 40.85 Billion JPY 99.388%
Human Metabolome Technologies, Inc. 656.68 Million JPY 61.911%
Precision System Science Co., Ltd. 2.25 Billion JPY 88.902%